glp-1 law suit Ozempic Lawsuit & Gastroparesis Victoza Lawsuit [2026 Update] |

Taken together, this series of studies suggests that the relative modest increase of endogenous GLP-1 activity via DPP-4Is may be insufficient to reach a therapeutic threshold

Exendin 939 directly binds to the TRPV1 channel To assess the direct interaction between exendin 939 and the TRPV1 channel, we conducted a protein binding assay using His-tagged exendin 939, which was able to pull down the TRPV1 channel (Fig

doi: 10.1111/nmo.14862

For liraglutide, NICE guidance (TA664) recommends similar BMI thresholds but with distinct eligibility criteria and specialist service requirements

Observational studies, case reports, and indirect mechanistic data generate compelling hypotheses but fall short of demonstrating causality or consistent clinical benefit in AITD